Inventor
ZABEAU LENNART
BE19 patents
⚠️ This page may combine multiple inventors who share the name “ZABEAU LENNART”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ORIONIS BIOSCIENCES INC
12 patentsUS10906985B2Feb 2, 2021
Targeted engineered interferon and uses thereof
ORIONIS BIOSCIENCES INC8 citations83
US11440943B2Sep 13, 2022
Therapeutic interferon alpha 1 proteins
ORIONIS BIOSCIENCES INC2 citations72
US12473338B2Nov 18, 2025
Targeted engineered interferon and uses thereof
ORIONIS BIOSCIENCES INC1 citations63
US12583898B2Mar 24, 2026
Therapeutic interferon alpha 1 proteins
ORIONIS BIOSCIENCES INC0 citations62
US12448447B2Oct 21, 2025
CD8 binding agents
ORIONIS BIOSCIENCES INC0 citations62
US12410225B2Sep 9, 2025
Modulation of dendritic cell lineages
ORIONIS BIOSCIENCES INC0 citations62
US12351614B2Jul 8, 2025
CLEC9A-based chimeric protein complexes
ORIONIS BIOSCIENCES INC0 citations62
US12351633B2Jul 8, 2025
PD-1 and PD-L1 binding agents
ORIONIS BIOSCIENCES INC0 citations62
US12091463B2Sep 17, 2024
Clec9A binding agents comprising a recombinant heavy-chain only antibody (VHH)
ORIONIS BIOSCIENCES INC1 citations62
US11566072B2Jan 31, 2023
CD8 binding agents
ORIONIS BIOSCIENCES INC1 citations62
US11498966B2Nov 15, 2022
PD-1 and PD-L1 binding agents
ORIONIS BIOSCIENCES INC1 citations62
US12583941B2Mar 24, 2026
Fibroblast activation protein binding agents and use thereof
ORIONIS BIOSCIENCES INC0 citations51
VIB VZW
4 patentsUS10072059B2Sep 11, 2018
Targeting of human interferon antagonists
VIB VZW19 citations93
US9732135B2Aug 15, 2017
Targeting of human interferon antagonists
VIB VZW23 citations93
US7575878B2Aug 18, 2009
Methods of inhibiting leptin-induced signaling with fibronectin III domain antibodies
VIB VZW13 citations84
US10947288B2Mar 16, 2021
Targeting of human interferon antagonists
VIB VZW6 citations83